Live Breaking News & Updates on Nick Opich

Stay updated with breaking news from Nick opich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap's Mental Health Technology


Mydecine Innovations Group, Inc., is pleased to announce that its subsidiary Mindleap Health a digital health platform and the world’s-first telemedicine application purpose-built for the psychedelic medicine industry, has filed a provisional patent for its technology platform in both The United States Patent and Trademark Office and the Canadian Intellectual Property Office. “As our company continues to innovate …
Mydecine Innovations Group, Inc., ( CSE:MYCO ) ( OTC:MYCOF ) ( FSE:0NFA ) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital health platform and the world’s-first telemedicine application purpose-built for the psychedelic medicine industry, has filed a provisional patent for its technology platform in both The United States Patent and Trademark Office (USPTO) and the Canadian Intellectual Property Office. ....

United States , Jack Bunce , Josh Bartch , Charles Lee , Joshua Bartch , Anne Donohoe Nick Opich , Mindleap Health , Corp Communication , Our Services , Mydecine Innovations Group Media Contacts , Mindleap Health Platform Services Disclaimer , Mindleap Health Inc , Trademark Office , Digital Mental Health , Canadian Securities Exchange , Canadian Intellectual Property Office , Mydecine Innovations Group Inc , Mindleap Services , Strategic Communications , Specialist Services , Mydecine Innovations Group , United States Patent , Canadian Intellectual Property , Chairman Josh , Mindleap Well Being , Innovations Group Media Contacts ,